[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
November 1983

Symptom Checklist Syndromes in the General PopulationCorrelations With Psychotherapeutic Drug Use

Author Affiliations

From the Department of Psychiatry, The University of Chicago (Dr Uhlenhuth); the Applied Therapeutics and Health Practices Program, National Institute of Mental Health, Bethesda, Md (Dr Balter); the Institute for Research in Social Behavior, Oakland, Calif (Dr Mellinger and Ms Clinthorne); and the Social Research Group, George Washington University, Washington, DC (Dr Cisin).

Arch Gen Psychiatry. 1983;40(11):1167-1173. doi:10.1001/archpsyc.1983.01790100013001

• Using symptom checklists administered on a large scale by survey interviewers in the 1979 National Survey of Psychotherapeutic Drug Use, we developed a method for classifying survey respondents by syndromes. These syndromes had symptoms and other characteristics consistent with their DSM-III diagnostic counterparts and showed one-year prevalence rates in accord with available epidemiologic data: Major Depression, 5.1%; Agoraphobia-Panic, 1.2%; Other Phobia, 2.3%; and Generalized Anxiety, 6.4%. However, the anxietyrelated syndromes occurred less frequently than clinical lore might suggest. The data showed a very low rate of antidepressant use and a higher rate of antianxiety agent use among Major Depressives (11% and 23%) and Agoraphobics (8% and 55%). Also noteworthy were the infrequent use of antianxiety agents among respondents with Generalized Anxiety (27%) and the low frequency of both antianxiety (19%) and antidepressant (3%) drug use among persons with high distress who did not qualify for any syndrome. These findings suggest that the majority of persons with serious psychiatric disorders still do not receive treatment or the most appropriate treatment.